Paroxysmal ventricular tachycardia is a critical condition often associated with coronary disease, but can be effectively controlled with therapies such as quinidine.
Answers are grounded in this paper and cite their sources.
Quinidine may aid paroxysmal VT control in select cases; leaves open need for randomized confirmation before practice change.
A review is presented of 107 cases of paroxysmal ventricular tachycardia. In the majority it was associated with acute coronary thrombosis or coronary sclerosis, in some with rheumatic valvular disease, and in others with no organic heart disease. It is generally critical and demands careful attention. Occasional cases are overlooked because only one heart sound is present for each cardiac cycle and the heart rate is misjudged to be one-half the actual rate. The outlook often is serious if the condition is not effectively treated. Therapy generally is successful in controlling the arrhythmia. The most valuable drug is quinidine. Other medications are magnesium sulfate, atropine, potassium salts, and possibly morphine.
No takes yet. Share an insight, caveat, or question.
Armbrust et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: